taurocholic acid has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruber, R; Hashem, O; Talebian, R | 1 |
| Hattori, T; Mukaisho, K; Saito, S; Sato, S; Sugihara, H; Yamamoto, G; Yamamoto, H | 1 |
2 other study(ies) available for taurocholic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Taurocholic acid lowers the inflammatory response of gingival fibroblasts, epithelial cells, and macrophages.
Topics: Animals; Carcinoma, Squamous Cell; Epithelial Cells; Fibroblasts; Gingiva; Humans; Macrophages; Mice; Mouth Neoplasms; Taurocholic Acid | 2020 |
Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Disease Progression; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Flow Cytometry; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; RNA, Messenger; Taurocholic Acid; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |